WorldPing
WorldPingSTAT
STAT+: FDA approves Ultragenyx gene therapy
Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout…
Brief by WorldPing · Original reporting by STAT
STAT
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
WorldPingA Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S.regulatory approval, capping a three-decade effort…
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATRelated news
WorldPing
WorldPingCointelegraph
Crypto generated about 1% of Webull’s record $198M Q2 revenue
While Webull reported a record $198 million in second-quarter revenue, cryptocurrency trading only generated about $2.25 million of the quarter’s revenue stream.
Brief by WorldPing · Original reporting by Cointelegraph
Hollywood Reporter
San Sebastian to Close With ‘Le Faux Soir,’ About Media Hack in Nazi-Occupied Belgium
Michaël R. Roskam returns to the Spanish festival in an out-of-competition slot.
Brief by WorldPing · Original reporting by Hollywood Reporter